发明名称 |
Method of treating neuronal injury by administering magnesium chloride and PEG |
摘要 |
The invention provides methods and kits for treatment of pain or inflammation. In one embodiment, the kit comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, an intra-articular administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant. |
申请公布号 |
US8840933(B2) |
申请公布日期 |
2014.09.23 |
申请号 |
US200611418153 |
申请日期 |
2006.05.03 |
申请人 |
Warsaw Orthopedic, Inc. |
发明人 |
Roy Josee;McKay William F.;Marx Jeffrey C |
分类号 |
A61K33/14;A61K31/765;A61K9/08;A61K9/00;A61K31/717;A61K31/787;A61K33/06 |
主分类号 |
A61K33/14 |
代理机构 |
Sorell, Lenna & Schmidt, LLP. |
代理人 |
Schmidt William D.;Sorell, Lenna & Schmidt, LLP. |
主权项 |
1. A method of reducing the volume of lesion due to a spinal cord injury or a traumatic brain injury in a subject in need thereof, the method comprising:
a) delivering to the subject a first injectable composition comprising magnesium chloride and 20-30% weight/volume of polyethylene glycol (PEG) in saline, wherein said magnesium chloride and PEG act synergistically to treat the injury; b) providing the dose of Mg in said magnesium chloride to be within a range from 0.115 to 0.230 mmol of Mg/kg of the subject's weight and providing the dose for PEG to be within a range from 0.7 to 1.4 g of PEG/kg of the subject's weight for the first injectable composition; c) delivering to the subject a second injectable composition comprising magnesium chloride and 20-30% weight/volume of PEG in saline within 24 hours of delivering the first injectable composition wherein said magnesium chloride and PEG act synergistically to treat the injury; d) providing the dose of Mg in said magnesium chloride to be within a range from 0.115 to 0.230 mmol of Mg/kg of the subject's weight and the dose for PEG to be within a range from 0.7 to 1.4 g of PEG/kg of the subject's weight for the second injectable composition; and e) observing at least 29% improvement in lesion volume over a similar dosage of Mg administered alone in saline due to the synergistic effect of co-administering Mg and PEG. |
地址 |
Warsaw IN US |